|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
|---|---|
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00018356 |
Purpose
This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
| Condition | Intervention | Phase |
|---|---|---|
|
Muscle Weakness Muscular Atrophy |
Procedure: exercise Drug: testosterone |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly |
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
The study will be limited to those patients who are metabolically stable and free of metastatic cancer and limiting end organ disease. Their total serum testosterone must be less than 480 and PSA less than 10.
Contacts and Locations
More Information
| Study ID Numbers: | AGCG-007-98S |
| Study First Received: | July 3, 2001 |
| Last Updated: | January 20, 2009 |
| ClinicalTrials.gov Identifier: | NCT00018356 History of Changes |
| Health Authority: | United States: Federal Government |
|
Aging nutrition rehabilitation |
|
Pathological Conditions, Anatomical Antineoplastic Agents, Hormonal Asthenia Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Methyltestosterone Muscle Weakness Hormones Testosterone 17 beta-cypionate |
Signs and Symptoms Anabolic Agents Testosterone Muscular Diseases Musculoskeletal Diseases Neurologic Manifestations Atrophy Muscular Atrophy Androgens |
|
Pathological Conditions, Anatomical Neuromuscular Manifestations Antineoplastic Agents, Hormonal Antineoplastic Agents Physiological Effects of Drugs Nervous System Diseases Hormones, Hormone Substitutes, and Hormone Antagonists Methyltestosterone Muscle Weakness Hormones Pharmacologic Actions Testosterone 17 beta-cypionate |
Signs and Symptoms Anabolic Agents Testosterone Muscular Diseases Pathologic Processes Musculoskeletal Diseases Therapeutic Uses Neurologic Manifestations Atrophy Muscular Atrophy Androgens |